Clinical Trials Website,, will List Coronavirus Clinical Trials at No Cost; Public Can Register to Receive Alerts about COVID-19 Clinical Trials

Thursday, March 19, 2020 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

Clinical trials to develop a vaccine to prevent COVID-19 are now underway. Speed is critical in enrolling volunteer participants so that trials can proceed as quickly as possible., a leading website for clinical trial searches and notifications will list COVID-19 clinical trials free-of-charge. Members of the public who register to receive free alerts will be notified about COVID-19 trials enrolling in their community that are listed on the website.

BOSTON, March 19, 2020 /PRNewswire-PRWeb/ --, a leading website for clinical trial information and notifications, is offering to list all clinical trials for the novel Coronavirus (COVID-19) free-of-charge on its searchable clinical trials website and notification engine. Members of who have indicated an interest in COVID-19 clinical trials will be alerted if they reside near a study site. Each year over three million people visit to search for clinical trials in their community and more than 650,000 members currently receive clinical trials notifications across numerous diseases and medical conditions.

"Speed is essential in effectively dealing with the unprecedented COVID-19 pandemic. Given our ability to rapidly reach hundreds of thousands of people interested in clinical trials participation, we saw a unique opportunity to be part of the solution -- helping researchers hasten patient enrollment in vaccine and other COVID-19 clinical trials," said Greg Conlan, Director of Operations for Therefore, effective immediately will waive the usual listing and outreach fees for pharmaceutical companies, clinical research sites and hospitals who post clinical trials for COVID-19 on The company will automatically apply a free listing discount when any COVID-19 study is posted. For additional information, please email: or call 1-800-887-0639.

Individuals who have not yet registered on to receive free Clinical Trial Alerts are urged to do so at They will be able to specify their interest in Clinical Trial Alerts about COVID-19 as well as study alerts for other diseases and medical conditions. Current members can update their profiles at any time to request notifications about newly listed clinical trials for COVID-19.

Research to develop and test a vaccine to protect against COVID-19 is ramping up quickly. The first clinical trial of a vaccine in Seattle, WA, testing 45 young, healthy volunteers is underway. Other clinical trial approaches may be available in the future. Associated Press (AP) reports that some researchers are hoping to quickly develop vaccines that provide temporary protection while a longer-lasting option is developed. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) says even if initial tests go well, it could take up to 18 months before a vaccine offering longer protection is available for widespread use.

Clinical study enrollment is one of the highest barriers to timely completion of clinical trials -- which can ultimately impact time-to-market for new pharmaceuticals and medical devices. Headquartered in Boston, Massachusetts, Clinical Connection, Inc. provides a patient recruiting clinical trials platform designed to help the clinical trials industry meet enrollment goals for clinical research studies. Clients include pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations (CROs) academic and independent clinical research centers, hospitals and physician practices engaged in clinical research. has listed over 40,000 clinical trials in the US and worldwide and has referred over one million participants to clinical research studies.

Contact Information Dan Wilde Clinical Connection, Inc 800-887-0639 Ext: 912


SOURCE Clinical Connection, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z



Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store